ENGINEERING CELLS FOR LIFE Trademark
Trademark Overview
On Thursday, January 19, 2023, a trademark application was filed for ENGINEERING CELLS FOR LIFE with the United States Patent and Trademark Office. The USPTO has given the ENGINEERING CELLS FOR LIFE trademark a serial number of 97761291. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Thursday, May 2, 2024. This trademark is owned by KSQ Therapeutics, Inc.. The ENGINEERING CELLS FOR LIFE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Medical and scientific research; providing medical and scientific research information; providing scientific information in the field of cell therapies, biotechnology, and drug development; research and development in the field of cell therapies, biotechnology, and drug development; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields
General Information
| Serial Number | 97761291 |
| Word Mark | ENGINEERING CELLS FOR LIFE |
| Filing Date | Thursday, January 19, 2023 |
| Status | 653 - SUSPENSION LETTER - MAILED |
| Status Date | Thursday, May 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Medical and scientific research; providing medical and scientific research information; providing scientific information in the field of cell therapies, biotechnology, and drug development; research and development in the field of cell therapies, biotechnology, and drug development; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 25, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, January 5, 2023 |
| First Use In Commerce Date | Thursday, January 5, 2023 |
Trademark Owner History
| Party Name | KSQ Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
Trademark Events
| Event Date | Event Description |
| Monday, January 23, 2023 | NEW APPLICATION ENTERED |
| Wednesday, January 25, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 17, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, October 18, 2023 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 18, 2023 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 18, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 9, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 9, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 9, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, February 9, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, February 9, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, February 9, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 30, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, April 30, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, April 30, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, May 2, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, May 2, 2024 | LETTER OF SUSPENSION E-MAILED |
| Thursday, May 2, 2024 | SUSPENSION LETTER WRITTEN |
